Partner Therapeutics, Inc. (PTx), a private, fully integrated biotechnology company, announced new data from a post hoc analysis of the eNRGy trial (NCT02912949), evaluating zenocutuzumab in patients ...
Prevention, screening, and vaccination are vital for managing infection risk during pregnancy due to altered maternal immunity.
Pfizer Inc. today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, ...
Evolutionary biologist Pamela Yeh and animal domestication expert Raffaela Lesch join Host Flora Lichtman to discuss how ...
Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating ...
Life begins with a single fertilized cell that gradually transforms into a multicellular organism. This process requires ...
The mystery of early embryonic communication is starting to be unraveled thanks to a new stem cell-based model.
Cell division is an essential process for all life on earth, yet the exact mechanisms by which cells divide during early ...
The maternal microbiome and immune system have both independent and synergistic effects on fetal brain health—changes in the ...
Accord BioPharma Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that Express Scripts, one of ...
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...
Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results